Abstract CT177: INO-5401 + INO-9012 in combination with atezolizumab for locally advanced unresectable or metastatic/recurrent urothelial carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs18-ct177
Abstract: Background: Advanced urothelial carcinoma (UCa; bladder cancer) remains a deadly disease with patients often failing to respond to, or ineligible for, platinum-based therapy. Checkpoint inhibitors (CPIs) have increased response rates, but a majority of patients… read more here.
Keywords: ino 9012; locally advanced; 5401 ino; advanced unresectable ... See more keywords